Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens LANCET INFECTIOUS DISEASES Inzaule, S. C., Hamers, R. L., Doherty, M., Shafer, R. W., Bertagnolio, S., de Wit, T. 2019; 19 (7): E246–E252

View details for DOI 10.1016/S1473-3099(18)30710-2

View details for Web of Science ID 000472818900005